Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04476472 · ClinicalTrials.gov registry record · NA
Omnipod Horizon™ Automated Glucose Control System Preschool Cohort
A NA study, sponsored by Insulet Corporation.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT04476472: Completed NA study, sponsored by Insulet Corporation.
NCT04476472 is a NA study that has completed, run by Insulet Corporation. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04476472, a NA study, has completed, sponsored by Insulet Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
Subjects will undergo a 14-day outpatient, standard therapy phase during which sensor and insulin data will be collected. This will be followed by a 94-day (13-week) hybrid closed-loop phase conducted in an outpatient setting, and an optional 12-month extension phase.
Primary Outcome
Number of severe hypoglycemia events reported in "events per person months" units.
Interventions
- DEVICE Omnipod Horizon™ Automated Glucose Control System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2020-09-08 |
| Est. Completion | 2022-10-12 |
| Phase | NA |
What the finished NCT04476472 record still lists
NCT04476472 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Omnipod Horizon™ Automated Glucose Control System is the first listed.
NCT04476472 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04476472 about?
NCT04476472 is a clinical study titled "Omnipod Horizon™ Automated Glucose Control System Preschool Cohort". Subjects will undergo a 14-day outpatient, standard therapy phase during which sensor and insulin data will be collected. This will be followed by a 94-day (13-week) hybrid closed-loop phase conducted in an outpatient setting, and an optional 12-month extension phase.
What is the current status of trial NCT04476472?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2020-09-08. Estimated completion is 2022-10-12.
What interventions are being tested in trial NCT04476472?
The interventions under investigation include: Omnipod Horizon™ Automated Glucose Control System (DEVICE).
Who is sponsoring clinical trial NCT04476472?
This trial is sponsored by Insulet Corporation, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04476472's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI